You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Boehringer Ingelheim
Baxter
Colorcon

Last Updated: April 6, 2020

DrugPatentWatch Database Preview

DEXTROSE 60% IN PLASTIC CONTAINER Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Dextrose 60% In Plastic Container, and when can generic versions of Dextrose 60% In Plastic Container launch?

Dextrose 60% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, and Hospira. and is included in four NDAs.

The generic ingredient in DEXTROSE 60% IN PLASTIC CONTAINER is dextrose. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the dextrose profile page.

Summary for DEXTROSE 60% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 60% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 60% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017995-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019346-001 Jan 25, 1985 DISCN No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-005 Mar 26, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare DEXTROSE 60% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-002 Jul 2, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Boehringer Ingelheim
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.